dobutamine has been researched along with vincaleukoblastine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kam, TS; Krishnan, P; Lee, FK; Lim, KH; Low, YY; Ting, KN; Yap, VA; Yong, KT | 1 |
1 review(s) available for dobutamine and vincaleukoblastine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for dobutamine and vincaleukoblastine
| Article | Year |
|---|---|
Schwarzinicines A-G, 1,4-Diarylbutanoid-Phenethylamine Conjugates from the Leaves of
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Ficus; HCT116 Cells; Humans; Molecular Structure; Phenethylamines; Plant Leaves; Rats | 2020 |